Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

A massage device for massaging by means of pressure waves includes a housing having a handle segment and a massage segment and at least one chamber comprising an opening leading outward in the massage segment. The chamber includes an end wall segment, a first circumferential wall segment, and a second circumferential wall segment, the first circumferential wall segment being disposed between the end wall segment and the second circumferential wall segment, and the second circumferential wall segment defining the opening with the end wall segment being at least partially displaceable. The massage device further includes a drive device for inducing a predetermined vibration in the end wall segment, with the first circumferential wall segment being substantially rigid and the second circumferential wall segment being substantially flexible.

The invention relates to a clitoris (12) stimulation apparatus (1) with improved ergonomics and comprising: a pressure field generating device (2) having a drive unit (6) and a hollow space (10), the drive unit (6) being capable of periodically generating a pressure field with alternating positive and negative pressures in the hollow space (10) when the drive unit varies the volume of the hollow space (10), said hollow space (10) having an opening (42) which can be placed on the clitoris (12); a control device (7) designed to control the drive unit (6); and a sensor device (78) designed to detect when the stimulation apparatus (1) comes close to the clitoris (12) or, alternatively, when the stimulation apparatus (1) comes into contact with the clitoris (12), and designed to output an activation signal to the control device (7) upon detection of any approximation or contact. The control device (7) is designed such that the drive unit (6) is activated in the presence of an activation signal. The pressure field generating device (2), the control device (7) and the sensor device (78) are accommodated in a housing (8) of the stimulation apparatus (1) and the stimulation apparatus (1) is designed as a portable handheld appliance.

A connector for an inflatable garment that detects a valid connection with a pump.

The present disclosure relates to thermal contrast therapy systems, and automated thermal contrast therapy devices configured to interact with such systems and to perform customized thermal contrast therapy treatment sequences. Treatments may be prescribed by a treatment provider or selected by a user of a thermal contrast therapy device associated with such a system. In some embodiments, a thermal contrast therapy device may be configured to receive an indication from one or more temperature sensors and/or flow meters and to effect a desired measure of heat transfer during treatment, for example, by automatically adjusting the temperature and/or flow rate of the heat transfer fluid. In some embodiments, a thermal contrast therapy device may be configured to receive an indication of one or more physiological parameter values and to perform a customized thermal contrast therapy treatment sequence based, at least in part, on the one or more physiological parameter values.

Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

A portable oscillating compression system including an for compressing air; an accumulator tank for receiving and storing the compressed air from the air compressor; an air pressure adjustment module for modulating pressure of the compressed air when the compressed air exits the accumulator tank; a valve body assembly attached to the accumulator tank, a plurality of inflatable cuffs connected to the valve body assemble for receiving the compressed air from the valve body assembly; a controller for controlling the valve body assembly; a power supply; and a housing for containing said system.

Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

A sleep assist system to monitor and assist the user's sleep, comprising a bedside device positioned near the user's bed, the bedside device comprising a loudspeaker and a light source and optionally a microphone, a light sensor, a temperature sensor, a control unit, an air quality sensor, a display unit, a user interface. The sleep assist system further comprises a first sensing unit positioned in the user's bed and comprising one or more sensors adapted to sense at least pressure and/or changes in pressure exerted by the user lying in the bed. The system monitors the user's sleep, assesses the user's sleep cycles and the phase of sleep cycle, and provides the user with at least one light and sound program, the light and sound program being based on the assessment of the user's sleep cycles and the phase of sleep cycle.